CTOs on the Move

Cognito Therapeutics

www.cognitotx.com

 
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer`s disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer`s disease and expects to start pivotal studies in 2022. The company`s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cognitotx.com
  • 1218 Massachusetts Avenue
    Cambridge, MA USA 02138
  • Phone: 857.201.5088

Executives

Name Title Contact Details

Similar Companies

QCL Quality Compliance Laboratories Inc

QCL Quality Compliance Laboratories Inc is a Markham, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Professional Gem Sciences Inc

Professional Gem Sciences Inc is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OrthoLive

OrthoLives mission is to leverage telehealth to streamline orthopedic care so practices and businesses can treat patients quickly.

XCELLENCE

XCELLENCE is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lyra Therapeutics

We are pioneering a new therapeutic approach to treat debilitating ear, nose and throat (ENT) diseases that impact the lives of millions of people.